- Alexion Pharmaceuticals (NASDAQ:ALXN): Q4 EPS of $1.30 beats by $0.01.
- Revenue of $599.48M (+35.7% Y/Y) beats by $9.03M.
- Press Release
Alexion Pharmaceuticals beats by $0.01, beats on revenue
Recommended For You
More Trending News
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ALXN | - | - |
Alexion Pharmaceuticals, Inc. |